I am delighted to welcome you to the new J Project Website, reconstructed with support from the Jeffrey Modell Foundation and the European Society for Immunodeficiency. This important event coincides with the recent great achievements of our Community.
It is hard to express the wonderful feeling throughout the year about the commitment of most of you to the shared mission of the J Project in 2020, under unusually difficult circumstances. A few of you, especially in Southern Europe recessed and withdrew. In contrast, the vast majority of colleagues realized that in difficult times we should be even stronger to carry on with our responsibility. Extending the scope of the traditional PID education program to PID-COVID-19 gave a unique strength to the J Project and resulted in a new dynamics by organizing another record number of meetings (attached).
Joining with the Casanova Lab at the Rockefeller University gave us the opportunity to join the coronavirus research in an active way, including the opening of several Participating Centers and invitation of speakers to present cutting edge research at several J Project meetings. Pertinent to this, the discovery of type 1 interferon deficiency in severe COVID-19 which was published in two companion papers in Science recently was selected by Nature among the 10 most remarkable discoveries from 2020 across all fields of science. The first authors of these two publications, Qian Zhang and Paul Bastard, presented their research at several J Project meetings from October to December.
We also took a remarkable step forward last year to a closer collaboration with ESID shown by the participation of ESID presidents Isabelle Meyts and Fabio Candotti as speakers at JP Meetings, and support of a number meeting by ESID in addition to the JMF and other sponsors. The new JP Website and the completion of the JP Book 2020 Part 2 by Melinda Erdős et al., before the end of the year were also important additions.
The J Daughters Central Asia project reached new milestones by joining Kyrgyzstan and Tajikistan as a result of outstanding contribution by Umida Nabieva, Tashkent, and Irina Tuzankina, Ekaterinburg.
This year was also very successful in terms of publishing joint papers. Two new papers in the J Clin Immunology, one on the Konya Declaration formulated at the 3rd J Project Congress organized by Ismail Reisli, and another one on the achievements of the J Siberia Project by Irina Tuzankina et al. were published this year. Based on Editorial Board invitation, Malgorzata Pac and co-editors JL Casanova, I Reisli, and L Maródi put together a remarkable set of 11 research papers from the Eastern and Central European J Project area in a separate volume of Frontiers in Immunology. Outstanding articles in Plos One by Oksana Boyarchuk et al., Ternopil, and in the Central Eur. J Immunol. by Alla Volokha et al., Kiev, also represent an increasing appearance of the J Project in the international medical literature.
These remarkable successes could only be achieved by the close collaboration of an orderly network with a shared vision and responsibility. We hope the coming year will see an uninterrupted activity of the J Project meeting program extending now to Far East Russia with local leadership of Galina Tcyvkina and colleagues. More unified standards of meetings and more research papers and presentations at international forums are needed. It is timely to summarize various parameters of PID diagnosis and treatment in a comprehensive review showing outcomes of the J Project and companion programs to improve the complex patient care in the 32 countries included now in our community.
While we have been resilient and productive as a community last year, I encourage everyone to increase efforts to remain connected to each other and to keep open doors to new regions and countries like Turkmenistan and Mongolia and welcome them as newcomers and to strengthen connection with partner organizations like ESID.
Debrecen-Budapest-New York, December, 2020.
November 14, 2020
Asghar Aghamohammadi (born in Ahvaz, Khuzestan province, Iran) was an Iranian medical scientist, immunologist and clinical immunology professor at the Tehran University of Medical Sciences. He has studied in many institutes, including the Ahvaz Jundishapur University of Medical Sciences, Tehran University of Medical Sciences, Great Ormond Street Hospital (Institute of Child Health) and the University of Toyama. He has been one of the most distinguished Iranian Immunologists and awarded many national scientific prizes for his works, mostly in the field of primary immunodeficiency. He was recognized internationally by hundreds of publications in this field and was the most important contributor to awareness of primary immunodeficiencies and to the management of immunodeficient patients in Iran. Read more…
November 14, 2020
Respecting the USERN slogan of “Science without Borders” and in order to eliminate the geographical border of science, the USERN Congress and Prize Awarding Festival is to be held annually hosted by a scientific center worldwide. Proudly, to date, we have organized the annual USERN Congresses and Festival in Iran (Tehran) USERN 2016, Ukraine (Kharkiv) USERN 2017, and Italy (Reggio Calabria) USERN 2018, Hungary (Budapest) USERN 2019, respectively; all highly welcomed by the international academic population.
Coming up next, the 5th USERN Congress and Prize Awarding Festival will be held on November 7-10, 2020 in the beautiful city of Tehran, Iran, in a hybrid model (attend “in-person” event with a “virtual” online component), which is also supported by J Project.
Now, in order to appreciate the J Project Activities, we would like to extend an invitation to all J Project Members. They are more than welcome to join us in USERN 2020 congress, virtually for FREE! Should they be interested, please use the link below to sign up:
November 14, 2020
President elect: Fabio Candotti
Secretary: Eleonora Gambineri
Treasurer: Stefano Volpi
Inborn Error Working Party: Michael Albert
Clinical Working Party: Siobahn Burns
This website reconstruction was supported by the Jeffrey Modell Foundation and the European Society for Immunodeficiencies